Biobank for Cholestatic Liver Diseases.

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT03445585
Status
Recruiting
Apply to this trial

Conditions

  • Cholangiocarcinoma
  • Liver Cancer
  • Primary Biliary Cirrhosis
  • Primary Sclerosing Cholangitis

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Accepted

Study Details

This study is a biobank of specimens and clinical data for use in current and future research to better understand the cholestatic liver diseases primary biliary cirrhosis/cholangitis (PBC) and primary sclerosing cholangitis (PSC).

Key Dates

Start date
Jan 31, 2017
Status verified
Feb 2026
Primary completion
Jan 31, 2050
Completion
Jan 31, 2050

Study Design

Enrollment
9,150 participants (estimated)

Arms

  • Arm: Primary Sclerosing Cholangitis
    Patients with a diagnosis of primary sclerosing cholangitis (PSC).
  • Arm: Primary Biliary Cirrhosis/Cholangitis
    Patients with a diagnosis of primary biliary cirrhosis (PBC).
  • Arm: Control group 1
    Patients who do not have PBC or PSC but do have another form of chronic liver disease.
  • Arm: Control group 2
    Patients without liver disease.

Primary Outcome Measure

Number of participants in the study. [ Time Frame: 20 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55901
Erik M Schlicht, CCRP
[email protected]
507-284-4312
Konstantinos N Lazaridis, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By condition
Liver cancer
By specialty
OncologyGI oncologyHepatology
By research site
Mayo Clinic· Rochester, MN

Related Studies